Client Login
A dual growth-hormone secretagogue research formulation combining 10mg CJC-1295 (No-DAC, Modified GRF 1-29) with 10mg Ipamorelin, studied for pulsatile GH release through complementary receptor pathways. Independent HPLC purity testing published per batch. Stored refrigerated at 2–8°C.
Sold for laboratory and research purposes only. Not for human consumption. 18+.
Great service and product and swift customer support
Eid D. · Verified buyer · Jul 2026Easy ordering and great service! Fantastic
James B. · Verified buyer · Jun 2026Very informative and helpful pre purchase and post. After care is incredible. Great job, keep it up
Omaad N. · Verified buyer · Jun 2026CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). Two variants of CJC-1295 exist in the research literature: CJC-1295 with DAC (Drug Affinity Complex), which covalently binds to albumin and has a half-life of several days; and CJC-1295 without DAC, also called Modified GRF 1-29 or Mod GRF, which carries the stabilising amino-acid substitutions but lacks the albumin-binding modification, giving it a half-life closer to native GHRH (around 30 minutes) and a pulsatile pattern of GH release in research models.
Ipamorelin is a selective pentapeptide ghrelin-receptor agonist (GHSR-1a agonist) that stimulates pulsatile GH release from the anterior pituitary. What distinguishes Ipamorelin in research is its high selectivity - studies consistently document robust GH pulse stimulation with minimal to no significant increase in cortisol, prolactin, or ACTH compared to earlier-generation secretagogues such as GHRP-2 or GHRP-6. This selectivity profile makes it a preferred tool for isolating GH axis effects without confounding hypothalamic-pituitary-adrenal (HPA) axis activation.
The combination of a GHRH analogue (CJC-1295 no-DAC) with a GHSR agonist (Ipamorelin) is studied for its synergistic effect on GH release: CJC-1295 amplifies the signal at the somatotroph level while Ipamorelin provides a separate receptor-mediated pulse trigger.
Additional research applications include sleep architecture studies (GH is predominantly released in slow-wave sleep), post-injury tissue remodelling investigation, and research into the relationship between GH axis function and metabolic rate.
Refrigeration at 2-8°C is required.
For research purposes only. Not approved for human therapeutic use in the UAE or elsewhere.
CJC-1295 (No-DAC), or Modified GRF 1-29, is a GHRH analogue with substitutions that resist enzymatic degradation. Lacking the Drug Affinity Complex of the DAC form, it has a short half-life and drives pulsatile, rather than sustained, somatotroph activation, which is why it is studied as a tool for physiological GH pulse dynamics. Ipamorelin is a selective GHSR-1a agonist studied for pulsatile GH release with minimal cortisol, prolactin, or ACTH effect.
Pairing a GHRH analogue with a GHSR-1a agonist is of interest because the two act on distinct receptor pathways; combined exposure has been reported to raise GH pulse amplitude and IGF-1 signalling in rodent models. Supplied for in vitro and laboratory research only.
Read the full guide: CJC-1295 & Ipamorelin: the research explained →
Open to everyone: the research behind each compound, our lab results and how we work.
A dual formulation of Ipamorelin (a selective GHSR-1a agonist) and CJC-1295 (a GHRH analogue), both studied in growth-hormone-axis research. For laboratory research only.
BodyPharm sells Ipamorelin CJC-1295 strictly for research purposes. Customers are responsible for understanding applicable regulations in their jurisdiction.
Ipamorelin is studied for selective, pulsatile GH release with little cortisol or prolactin effect. This product is the no-DAC CJC-1295 (Modified GRF 1-29), short half-life and pulsatile in research models unlike the sustained DAC form; combined exposure has raised IGF-1 in rodent studies.
They act on distinct receptors (GHRH receptor and GHSR-1a); together they may amplify GH pulsatility, a useful tool for somatotropic-axis studies.
Next day across the UAE by cold-chain courier, in insulated packaging with ice packs.
All of our products are rigorously tested to pharmaceutical industry standards. This includes full in-house testing and third-party testing across our entire range. Batch test reports and certificates are published on each product page, which you can reach once you are signed in.
Our products are sold strictly for research purposes only. We do not make any medical claims or provide usage guidance.
Due to the nature of our products, we cannot accept returns on any items. For any issues, please message our customer support team.
All products are sold strictly for research and laboratory use only.
Access is restricted to adults 18 and over. We’re unable to grant access.
You won’t be asked again on this device.